| Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 … L Semenzato, J Botton, J Drouin, F Cuenot, R Dray-Spira, A Weill, ... The Lancet Regional Health–Europe 8, 2021 | 215 | 2021 |
| Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in people aged 75 years or older MJ Jabagi, J Botton, M Bertrand, A Weill, P Farrington, M Zureik, ... Jama 327 (1), 80-82, 2022 | 131 | 2022 |
| Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients L Semenzato, J Botton, J Drouin, B Baricault, C Vabre, F Cuenot, L Penso, ... Hypertension 77 (3), 833-842, 2021 | 120 | 2021 |
| Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs PO Blotière, F Raguideau, A Weill, E Elefant, I Perthus, V Goulet, ... Neurology 93 (2), e167-e180, 2019 | 98 | 2019 |
| Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study A Weill, P Nguyen, M Labidi, B Cadier, T Passeri, L Duranteau, AL Bernat, ... bmj 372, 2021 | 92 | 2021 |
| Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines S Le Vu, M Bertrand, MJ Jabagi, J Botton, J Drouin, B Baricault, A Weill, ... Nature communications 13 (1), 3633, 2022 | 80 | 2022 |
| Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based … PO Blotière, S Miranda, A Weill, Y Mikaeloff, H Peyre, F Ramus, ... BMJ open 10 (6), e034829, 2020 | 58 | 2020 |
| Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France J Coste, PO Blotiere, S Miranda, Y Mikaeloff, H Peyre, F Ramus, M Zureik, ... Scientific Reports 10 (1), 17362, 2020 | 57 | 2020 |
| Association between biologics use and risk of serious infection in patients with psoriasis L Penso, R Dray-Spira, A Weill, LP Vegas, M Zureik, E Sbidian JAMA dermatology 157 (9), 1056-1065, 2021 | 49 | 2021 |
| A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety Y Ghebremichael‐Weldeselassie, MJ Jabagi, J Botton, M Bertrand, ... Statistics in Medicine 41 (10), 1735-1750, 2022 | 44 | 2022 |
| Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study L Hoisnard, LP Vegas, R Dray-Spira, A Weill, M Zureik, E Sbidian Annals of the Rheumatic Diseases 82 (2), 182-188, 2023 | 42 | 2023 |
| Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010‐2018 A Meyer, J Drouin, A Weill, F Carbonnel, R Dray‐Spira Alimentary Pharmacology & Therapeutics 52 (9), 1480-1490, 2020 | 41 | 2020 |
| Risk for myocardial infarction, stroke, and pulmonary embolism following COVID-19 vaccines in adults younger than 75 years in France J Botton, MJ Jabagi, M Bertrand, B Baricault, J Drouin, S Le Vu, A Weill, ... Annals of internal medicine 175 (9), 1250-1257, 2022 | 40 | 2022 |
| Intravitreal anti–vascular endothelial growth factor use in France during the coronavirus disease 2019 pandemic SB de Gage, J Drouin, D Desplas, F Cuenot, R Dray-Spira, A Weill, ... JAMA ophthalmology 139 (2), 240-242, 2021 | 36 | 2021 |
| Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study H Jourdain, SB de Gage, D Desplas, R Dray-Spira The Lancet Public Health 7 (6), e529-e536, 2022 | 33 | 2022 |
| Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines J Botton, R Dray-Spira, B Baricault, J Drouin, M Bertrand, MJ Jabagi, ... Vaccine 40 (3), 414-417, 2022 | 33 | 2022 |
| Colonoscopy in France during the COVID-19 pandemic A Meyer, J Drouin, M Zureik, A Weill, R Dray-Spira International journal of colorectal disease 36, 1073-1075, 2021 | 32 | 2021 |
| Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study L Pina Vegas, P Le Corvoisier, L Penso, M Paul, E Sbidian, ... Rheumatology 61 (4), 1589-1599, 2022 | 31 | 2022 |
| Risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis initiating interleukin‐17 inhibitors: a nationwide population‐based … L Penso, C Bergqvist, A Meyer, P Herlemont, A Weill, M Zureik, ... Arthritis & Rheumatology 74 (2), 244-252, 2022 | 31 | 2022 |
| Risk of severe COVID‐19 in patients treated with IBD medications: a French nationwide study A Meyer, L Semenzato, M Zureik, A Weill, F Carbonnel, R Dray‐Spira Alimentary Pharmacology & Therapeutics 54 (2), 160-166, 2021 | 31 | 2021 |
Mahmoud ZureikEpi-Phare (epi-phare.fr)Verified email at ansm.sante.fr
